Our team of leading experts at Dana-Farber Brigham Cancer Center offers patients with cervical cancer the most advanced treatments and state-of-the-art technology coupled with compassionate, supportive care. Our cervical cancer team works closely with each patient throughout their cancer journey, from diagnosis and treatment through follow-up care, to provide a personalized care plan.
Dana-Farber Brigham Cancer Center includes experts across disciplines and specialties from both Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI). From medical and surgical oncology to radiology, gynecology, pathology and nursing, our two institutions work together as one, creating a seamless experience for patients while providing top expertise and comprehensive care.
Our board-certified surgeons are world leaders in minimally invasive surgical approaches, including fertility sparing surgery options, for cervical cancer and other gynecologic cancers. We develop a personalized surgical plan for each patient and can offer several treatment options to optimize your care. As leading cancer researchers, we can make recommendations for cervical cancer treatment based on the very latest research.
In addition to expert diagnosis and treatment, we offer a wealth of supportive resources, including complementary therapies like massage and acupuncture, nutritional counseling and emotional support. Our patient navigator is always available to provide personalized education, support and a wide range of other helpful resources, and our clinicians and support staff communicate with you and your family every step of the way, partnering with specialists and referring physicians to coordinate your care. Our goal is to take care of all the details so you can focus on healing.
Cervical cancer is a type of cancer that starts growing in the cells of the cervix, at the lower end of the uterus. Cervical cancer usually grows slowly and begins with precancerous cells, which can be detected by a Pap test and HPV test.
Low-grade SIL. These are early changes in cells on the surface of the cervix. The changes may go away on their own, or they may become more abnormal. This type may also be called mild dysplasia or CIN 1.
High-grade SIL. These are changes in many of the cells on the surface of the cervix. While it may take months or years for these cells to become cancer, without treatment, they eventually will become cancer. This type of precancer may also be called moderate or severe dysplasia, CIN 2 or 3 or carcinoma in situ.
Because cervical cancer usually grows slowly and begins with precancerous cells, routine Pap tests can help prevent cervical cancer or find it at an early . Persistent HPV testing can also help prevent adenocarcinoma in situ, which are precancer cells of the cervical canal that may be harder to detect on routine screening.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.
About BWH
